CN108617970A - 一种回回豆营养素及其制备方法 - Google Patents
一种回回豆营养素及其制备方法 Download PDFInfo
- Publication number
- CN108617970A CN108617970A CN201810300935.XA CN201810300935A CN108617970A CN 108617970 A CN108617970 A CN 108617970A CN 201810300935 A CN201810300935 A CN 201810300935A CN 108617970 A CN108617970 A CN 108617970A
- Authority
- CN
- China
- Prior art keywords
- semen
- weight
- cassiae nodosae
- parts
- nodosae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000582 semen Anatomy 0.000 title claims abstract description 78
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 150000004676 glycans Chemical class 0.000 claims abstract description 15
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 15
- 239000005017 polysaccharide Substances 0.000 claims abstract description 15
- 241000221377 Auricularia Species 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000012535 impurity Substances 0.000 claims description 6
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 230000003247 decreasing effect Effects 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 239000008103 glucose Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 230000000291 postprandial effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000045232 Canavalia ensiformis Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000013546 non-drug therapy Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本申请公开了一种回回豆营养素及其制备方法。所述回回豆营养素包括70‑90重量份回回豆、10‑25重量份木耳多糖和1‑5重量份荷叶碱。所述方法包括：将70‑90重量份回回豆、10‑25重量份木耳多糖和1‑5重量份荷叶碱混合均匀，得到所述回回豆营养素。本申请的回回豆营养素具有良好的减肥和降血糖效果，并且制备方法简单。
Description
技术领域
本申请涉及但不限于一种具有减肥和降血糖功效的回回豆营养素及其制备方法。
背景技术
目前，我国糖尿病患者数量正以惊人的速度急剧增加，并且有年轻化趋势，直接威胁着人们的健康。糖尿病是一种终身性疾病，其严重性在于并发症的发生率较高，如动脉粥样硬化、冠心病、心肌梗塞、脑卒中、下肢动脉缺血或闭塞(又称为糖尿病大血管并发症)、酮症酸中毒等，是造成患者丧失劳动力、致死致残的主要因素。如何科学防治糖尿病，以前更多的侧重于药物治疗，近几年来随着营养学的研究发展和健康饮食知识的普及，越来越多的非药物治疗方法不断涌现，例如，饮食疗法、保健疗法等。
发明内容
以下是对本文详细描述的主题的概述。本概述并非是为了限制权利要求的保护范围。
本申请提供了一种具有减肥和降血糖功效的回回豆营养素及其制备方法。
具体地，本申请提供了一种回回豆营养素，所述回回豆营养素包括70-90重量份回回豆、10-25重量份木耳多糖和1-5重量份荷叶碱。
在一些实施方式中，所述回回豆营养素可以包括70-80重量份回回豆、10-12重量份木耳多糖和1-3重量份荷叶碱。
在一些实施方式中，所述回回豆可以为炒熟的回回豆。
在一些实施方式中，所述回回豆可以通过80目筛。
本申请还提供了一种制备回回豆营养素的方法，所述方法包括：将70-90重量份回回豆、10-25重量份木耳多糖和1-5重量份荷叶碱混合均匀，得到所述回回豆营养素。
在一些实施方式中，所述回回豆可以为炒熟的回回豆。
在一些实施方式中，所述回回豆可以通过80目筛。
在一些实施方式中，所述方法还可以包括：挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛。
本申请中，各种组分的作用与功效如下：
荷叶：由荷叶碱、柠檬酸、苹果酸等组成，具有清热解暑、升发清阳、除湿祛瘀、利尿通便和健脾升阳的作用。荷叶的减肥原理是服用后在人体肠壁上形成一层脂肪隔离膜，有效阻止脂肪的吸收，从根本上减重，并更有效控制反弹。
木耳多糖：木耳多糖为木耳的提取物，由L-岩藻糖、L-阿拉伯糖、D-木糖、D-甘露糖、D-葡萄糖和葡萄糖醛酸等单糖组成，实体中含酸性粘多糖，具有降血糖、降血脂、抗衰老、抗溃疡、抗放射、抗血栓形成、提高机体免疫功能、增强机体抗病能力等作用。
回回豆：《中药大辞典》记载其为蝶形花科草本植物，别名胡豆、回鹘豆、那和豆、鹰嘴豆、鸡豆。《本草拾遗》中指出回回豆“主消渴”。《五杂俎》中提出回回豆能解面毒。回回豆是印度和巴基斯坦的重要的五谷之一，在欧洲食用回回豆也十分普遍，也是回医常用药材。其种子成分含蛋白质约18.4～29.8％、脂肪油4.6～6.10％、淀粉44.89～52.80％、矿物质2.36～4.67％、粗纤维2.4～10.06％。蛋白质是完全蛋白，脂类中尚含胆碱磷脂，其胆碱含量为116～238毫克％，磷脂P2O5含量为102～136毫克％。碳水化合物中除淀粉和粗纤维外，尚含阿糖配葡聚糖(Arabi-noglucglycan)0.8～1.2％，其中L-阿拉伯糖与D-葡萄糖之比为3：7，水溶性糖6.7％，其中包括葡萄糖、蔗糖和鹰嘴豆糖(Cicerose，是一种四糖，由二分子半乳糖，一分子葡萄糖和一分子果糖构成)。回回豆中含有胰蛋白酶抑制物，比较耐热，须久煮才能破坏。新收获的回回豆种子含维生素C1031毫克/100克，几乎为新收小麦的1倍，但豆粒放陈后维生素C的含量只有2.5～6毫克/100克。此外，种子尚含磷308毫克％、钙231毫克、铁6.9毫克％、植酸(Phytic acid)磷354毫克％、及维生素E、硫胺素、泛酸等。回回豆中含有的高蛋白、高不饱和脂肪酸、高纤维素、高钙、高锌、高钾、高维生素B等是有益于人体健康的营养素。回回豆中含有微量元素铬，铬在机体的糖代谢和脂肪代谢中发挥着重要作用。糖尿病患者正是因为胰岛素相对或绝对不足引起糖代谢、脂肪代谢、蛋白质代谢紊乱。铬是葡萄糖耐量因子(GTF)的组成部分，回回豆对糖尿病具有控制、降低血糖，预防和减缓糖尿病并发症的作用，世界各地都有关于糖尿病患者铬含量低于健康人的报道。人体血糖代谢的调节取决于3个因素的水平和协调作用，这3个因素是胰岛素、葡萄糖耐量受体和胰岛受体。人体含铬量减少，就会导致胰岛素活性降低，受体数量减少，糖耐量受损，从而引发糖尿病。
本申请的回回豆营养素在众多肥胖病人身上都取得了很好的减肥效果，轻度糖尿病病人也得到了康复，体重减至正常水平的占95％以上，其中糖尿病占总人数的80％，血糖降至正常水平约90％。
本申请的其它特征和优点将在随后的说明书中阐述，并且，部分地从说明书中变得显而易见，或者通过实施本申请而了解。本申请的目的和其他优点可通过在说明书以及权利要求书中所特别指出的结构来实现和获得。
具体实施方式
为使本申请的目的、技术方案和优点更加清楚明白，下文中将对本申请的实施例进行详细说明。需要说明的是，在不冲突的情况下，本申请中的实施例及实施例中的特征可以相互任意组合。
以下实施例中所使用的回回豆、木耳多糖和荷叶碱均通过商购获得。
实施例1
挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛；
称量80重量份回回豆、15重量份木耳多糖和5重量份荷叶碱混合均匀，经过紫外线消毒，机器包装再消毒，得到所述回回豆营养素。
实施例2
挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛；
称量70重量份回回豆、25重量份木耳多糖和5重量份荷叶碱混合均匀，经过紫外线消毒，机器包装再消毒，得到所述回回豆营养素。
实施例3
挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛；
称量80重量份回回豆、12重量份木耳多糖和3重量份荷叶碱混合均匀，经过紫外线消毒，机器包装再消毒，得到所述回回豆营养素。
实施例4
挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛；
称量90重量份回回豆、10重量份木耳多糖和1重量份荷叶碱混合均匀，经过紫外线消毒，机器包装再消毒，得到所述回回豆营养素。
临床应用典型案例
以下案例的患者均服用实施例1的回回豆营养素，每日服用60g，分三次服用。
1、欧洲某总统夫人，身高160公分，体重96公斤，患2型糖尿病15年，平时吃三种降血糖的西药，空腹血糖18-22mmol/L，并且患9种慢性病，平时服用的21种西药。服用回回豆营养素加上回医治疗糖尿病的系统调理，三个月后体重减掉34公斤，血糖降至5.6-8mmol/L。
2、俄罗斯某男，38岁，身高181，体重259公斤。服用回回豆营养素10天，同时用顺势疗法减肥，10天减掉体重30公斤，坚持了18个月，体重降至正常。
3、宁夏马某，25岁，身高183，体重110公斤，心肌酶升高，肝功异常，伴发心绞痛。服用回回豆营养素加顺势疗法减肥，3个月减掉30公斤，心脏肝功恢复正常。
4、新疆的陆某某，男58岁，身高192，体重116公斤，餐前血糖14.6mmol/L，餐后2小时21mmol/L，血压160-110mmHg。服用回回豆营养素1个月，体重降至89公斤，血压、血脂、血糖正常，随访一年诸项指标正常。
5、宁夏银川田某某，男25岁，身高180CM，体重110公斤，确诊糖尿病4年，餐前血糖11mmol/L，餐后18mmol/L。服用回回豆营养素3个月，体重降至78公斤，血糖正常，随访一年情况稳定。
6、鄂尔多斯马某某，男52岁，身高175CM，重96公斤，确诊为2型糖尿病6年，餐前血糖14.7mmol/L，餐后21mmol/L。服用回回豆营养素3个月，体重降至79公斤，餐前血糖4-5mmol/L，餐后6-8个单位，随访一年指标正常。
实施例2-4的回回豆营养素也具有与如上所述类似的功效。
虽然本申请所揭露的实施方式如上，但所述的内容仅为便于理解本申请而采用的实施方式，并非用以限定本申请。任何本申请所属领域内的技术人员，在不脱离本申请所揭露的精神和范围的前提下，可以在实施的形式及细节上进行任何的修改与变化，但本申请的专利保护范围，仍须以所附的权利要求书所界定的范围为准。
Claims (8)
1.一种回回豆营养素，所述回回豆营养素包括70-90重量份回回豆、10-25重量份木耳多糖和1-5重量份荷叶碱。
2.根据权利要求1所述的回回豆营养素，其中，所述回回豆营养素包括70-80重量份回回豆、10-12重量份木耳多糖和1-3重量份荷叶碱。
3.根据权利要求1或2所述的回回豆营养素，其中，所述回回豆为炒熟的回回豆。
4.根据权利要求3所述的回回豆营养素，其中，所述回回豆能通过80目筛。
5.一种制备回回豆营养素的方法，所述方法包括：将70-90重量份回回豆、10-25重量份木耳多糖和1-5重量份荷叶碱混合均匀，得到所述回回豆营养素。
6.根据权利要求5所述的方法，其中，所述回回豆为炒熟的回回豆。
7.根据权利要求5或6所述的方法，其中，所述回回豆能通过80目筛。
8.根据权利要求5所述的方法，所述方法还包括：挑出回回豆中的杂质，将回回豆洗净、烘干、炒熟、粉碎以及过80目筛。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810300935.XA CN108617970A (zh) | 2018-04-04 | 2018-04-04 | 一种回回豆营养素及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810300935.XA CN108617970A (zh) | 2018-04-04 | 2018-04-04 | 一种回回豆营养素及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108617970A true CN108617970A (zh) | 2018-10-09 |
Family
ID=63704991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810300935.XA Pending CN108617970A (zh) | 2018-04-04 | 2018-04-04 | 一种回回豆营养素及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108617970A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101133837A (zh) * | 2007-10-24 | 2008-03-05 | 中国科学院新疆理化技术研究所 | 一种鹰嘴豆营养粉及其制备方法 |
| CN101341972A (zh) * | 2007-07-09 | 2009-01-14 | 西安汇源科技开发有限公司 | 一种可以调控血糖的食品及其制备方法 |
| CN102599440A (zh) * | 2012-04-12 | 2012-07-25 | 中国科学院新疆理化技术研究所 | 一种鹰嘴豆蛋白营养粉及其制备方法 |
| CN104106828A (zh) * | 2013-04-18 | 2014-10-22 | 付国福 | 一种降血糖的固体饮料 |
| CN107509925A (zh) * | 2017-07-07 | 2017-12-26 | 杨雪林 | 一种减肥面粉 |
| KR101834764B1 (ko) * | 2014-09-26 | 2018-03-08 | 대한민국 | 유효성분의 함량이 향상된 콩 유래 추출물 |
-
2018
- 2018-04-04 CN CN201810300935.XA patent/CN108617970A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101341972A (zh) * | 2007-07-09 | 2009-01-14 | 西安汇源科技开发有限公司 | 一种可以调控血糖的食品及其制备方法 |
| CN101133837A (zh) * | 2007-10-24 | 2008-03-05 | 中国科学院新疆理化技术研究所 | 一种鹰嘴豆营养粉及其制备方法 |
| CN102599440A (zh) * | 2012-04-12 | 2012-07-25 | 中国科学院新疆理化技术研究所 | 一种鹰嘴豆蛋白营养粉及其制备方法 |
| CN104106828A (zh) * | 2013-04-18 | 2014-10-22 | 付国福 | 一种降血糖的固体饮料 |
| KR101834764B1 (ko) * | 2014-09-26 | 2018-03-08 | 대한민국 | 유효성분의 함량이 향상된 콩 유래 추출물 |
| CN107509925A (zh) * | 2017-07-07 | 2017-12-26 | 杨雪林 | 一种减肥面粉 |
Non-Patent Citations (1)
| Title |
|---|
| 迷罗著: "《24节气养生法》", 31 August 2015, 吉林科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vuksan et al. | Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus | |
| Alarcon-Aguilar et al. | Hypoglycemic effect of extracts and fractions from Psacalium decompositum in healthy and alloxan-diabetic mice | |
| CN101637255B (zh) | 一种降糖营养粉 | |
| CN103750107B (zh) | 一种具有降糖功能的保健品 | |
| CN101234142B (zh) | 一种以辅助降血糖为主的桑系列保健功能性饮料 | |
| CN102526478B (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
| CN102526479B (zh) | 一种增强免疫力、降血糖功能的保健药物 | |
| CN106689959A (zh) | 一种辅助调节血糖的固体饮料 | |
| CN104543834A (zh) | 一种具有降血糖功效的南瓜粉及其制备方法 | |
| CN103300188A (zh) | 一种苦荞降糖颗粒茶及其制作方法 | |
| Kaur et al. | Indian culinary plants enhance glucose-induced insulin secretion and glucose consumption in INS-1 β-cells and 3T3-L1 adipocytes | |
| CN102113534A (zh) | 一种具有治疗糖尿病功能的月饼及其制备方法 | |
| CN101953867B (zh) | 天山雪莲石油醚提取物及其应用制备方法和应用 | |
| CN102078397B (zh) | 一种中药复方及其制备方法 | |
| CN101406602B (zh) | 一种治疗ⅱ型糖尿病的七味地黄降糖胶囊 | |
| CN1101133C (zh) | 具有降血糖作用的缮食纤维百乐饼干的配方及其生产工艺 | |
| CN108617970A (zh) | 一种回回豆营养素及其制备方法 | |
| CN1297353A (zh) | 降血糖剂 | |
| CN105055851B (zh) | 一种治疗糖尿病的中药组合物、其制剂及其应用 | |
| CN107412618A (zh) | 一种黄精洋参养生茶及其制备方法 | |
| CN105533596A (zh) | 一种蜂胶参银胶囊及其制备方法 | |
| CN106729304B (zh) | 一种减轻禁食或节食副反应的中药及其制备方法 | |
| CN105031248A (zh) | 一种含有硒虫草的可辅助降血糖的保健品 | |
| CN1135856A (zh) | 一种对糖尿病有效的保健食品及其制法 | |
| CN1970058A (zh) | 一种治疗糖尿病的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181009 |